7月15日，Elevance Health盘中下跌8.18%，报391.885美元/股，成交额5357.04万美元。
消息面上，公司盘前发布二季度财报：调整后每股收益7.45美元，超市场预期6.21美元约20%；营收498.3亿美元，超预期约12亿美元，同时上调全年调整后每股收益指引至至少27美元。然而，二季度每股收益同比下降15.72%，营业利润率从去年同期的4.9%大幅降至3.5%，利润率压缩引发市场担忧。此外，公司CEO在电话会议中表示将在未来12至18个月内退出更多州的医疗补助市场，叠加前期多家投行密集上调目标价后股价已累积较大涨幅，利好兑现压力显著。管理型保健护理板块整体承压，联合健康跌2.04%，康西哥跌2.52%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.